Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 388

1.

Postoperative radiotherapy for uterine cervical cancer: impact of lymph node and histological type on survival.

Kasuya G, Ogawa K, Iraha S, Nagai Y, Hirakawa M, Toita T, Kakinohana Y, Kudaka W, Inamine M, Ariga T, Aoki Y, Murayama S.

Anticancer Res. 2013 May;33(5):2199-204.

PMID:
23645776
2.

Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors.

Uno T, Ito H, Itami J, Yasuda S, Isobe K, Hara R, Sato T, Minoura S, Shigematsu N, Kubo A.

Anticancer Res. 2000 May-Jun;20(3B):2235-9.

PMID:
10928184
4.

Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.

Okazawa M, Mabuchi S, Isohashi F, Suzuki O, Yoshioka Y, Sasano T, Ohta Y, Kamiura S, Ogawa K, Kimura T.

Int J Gynecol Cancer. 2013 Mar;23(3):567-75. doi: 10.1097/IGC.0b013e31828703fd.

PMID:
23385284
5.

Simultaneous modulated accelerated radiotherapy in cervical cancer with retroperitoneal lymph node metastasis after radical hysterectomy and pelvic lymphadenectomy.

Li XL, Chen ZY, Cui YC, Sheng XG.

Int J Gynecol Cancer. 2015 Jun;25(5):903-9. doi: 10.1097/IGC.0000000000000426.

PMID:
25822099
6.

Postoperative pelvic radiotherapy for cervical cancer patients with positive parametrial invasion.

Uno T, Ito H, Isobe K, Kaneyasu Y, Tanaka N, Mitsuhashi A, Suzuka K, Yamazawa K, Shigematsu N, Itami J.

Gynecol Oncol. 2005 Feb;96(2):335-40.

PMID:
15661218
7.

Risk factors and prognosis of IB-IIB cervical carcinoma with common iliac lymph node metastasis.

Huang L, Zheng M, Liu JH, Xiong Y, Ding H, Tang L, Wang HY.

Chin J Cancer. 2010 Apr;29(4):431-5.

8.

[Clinical analysis of the recurrence of early stage bulky cervical carcinoma].

Hu JL, Wu LY, Li XG, Zhang R, Li N, Yao HW.

Zhonghua Zhong Liu Za Zhi. 2012 May;34(5):378-81. doi: 10. 3760/cma.j.issn.0253-3766.2012.05.014. Chinese.

PMID:
22883461
9.

Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy.

Ayhan A, Al RA, Baykal C, Demirtas E, Ayhan A, Yüce K.

Int J Gynecol Cancer. 2004 Mar-Apr;14(2):286-92.

PMID:
15086728
10.

Postoperative radiotherapy in early stage carcinoma of the uterine cervix: treatment results and prognostic factors.

Yeh SA, Wan Leung S, Wang CJ, Chen HC.

Gynecol Oncol. 1999 Jan;72(1):10-5.

PMID:
9889023
11.
12.

The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study.

Yin YJ, Li HQ, Sheng XG, Du XL, Wang C, Lu CH, Pan CX.

Int J Gynecol Cancer. 2015 Jul;25(6):1058-65. doi: 10.1097/IGC.0000000000000360.

PMID:
25647254
13.

Radical surgery with individualized postoperative radiation for stage IB cervical cancer: oncologic outcomes and severe complications.

Sandadi S, Tanner EJ, Khoury-Collado F, Kostolias A, Makker V, Chi DS, Sonoda Y, Alektiar KM, Barakat RR, Abu-Rustum NR.

Int J Gynecol Cancer. 2013 Mar;23(3):553-8. doi: 10.1097/IGC.0b013e3182849d53.

PMID:
23392402
14.

Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma.

Monk BJ, Cha DS, Walker JL, Burger RA, Ramsinghani NS, Manetta A, DiSaia PJ, Berman ML.

Gynecol Oncol. 1994 Jul;54(1):4-9.

PMID:
8020837
15.

Prognostic factors in definitive radiotherapy of uterine cervical cancer.

Yalman D, Aras AB, Ozkök S, Duransoy A, Celik OK, Ozsaran Z, Haydaroğlu A.

Eur J Gynaecol Oncol. 2003;24(3-4):309-14.

PMID:
12807246
16.

Comparison of the prognoses of FIGO stage I to stage II adenosquamous carcinoma and adenocarcinoma of the uterine cervix treated with radical hysterectomy.

Mabuchi S, Okazawa M, Kinose Y, Matsuo K, Fujiwara M, Suzuki O, Morii E, Kamiura S, Ogawa K, Kimura T.

Int J Gynecol Cancer. 2012 Oct;22(8):1389-97.

PMID:
22976497
17.

Operable Stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy.

Atlan D, Touboul E, Deniaud-Alexandre E, Lefranc JP, Antoine JM, Jannet D, Lhuillier P, Uzan M, Huart J, Genestie C, Antoine M, Jamali M, Ganansia V, Milliez J, Uzan S, Blondon J.

Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):780-93.

PMID:
12377330
18.

Prognostic factors in patients with with locally advanced cervical cancer treated with radical hysterectomy and adjuvant radiotherapy.

Frigerio L, Mariani A, Gandini L, Origoni M, Galli L, Rabaiotti E, Aletti G, Ferrari A.

Int Surg. 1998 Jul-Sep;83(3):265-70.

PMID:
9870789
19.

Impact of histological subtype on survival of patients with surgically-treated stage IA2-IIB cervical cancer: adenocarcinoma versus squamous cell carcinoma.

Mabuchi S, Okazawa M, Matsuo K, Kawano M, Suzuki O, Miyatake T, Enomoto T, Kamiura S, Ogawa K, Kimura T.

Gynecol Oncol. 2012 Oct;127(1):114-20. doi: 10.1016/j.ygyno.2012.06.021. Epub 2012 Jun 21.

PMID:
22728518
20.

Class II radical hysterectomy for stage I-IIA cervix cancer: prognostic factors associated to recurrence and survival in a northeast Brazil experience.

Bezerra AL, Martins MR, Bezerra SM, Figueiroa JN, Batista TP.

J Surg Oncol. 2011 Sep 1;104(3):255-9. doi: 10.1002/jso.21939. Epub 2011 Apr 4.

PMID:
21465491

Supplemental Content

Support Center